此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Coupling of Neural Activity and Retinal Blood Flow in Diabetes

2020年2月19日 更新者:Gerhard Garhofer、Medical University of Vienna

The prevalence of diabetes is increasing and the management of the disease is nowadays considered a major challenge. Affected patients have increased mortality and morbidity as well as a significant drop in the quality of life. The complications of diabetes can be classified as microvascular (e.g. nephropathy, neuropathy or retinopathy) or macrovascular (e.g. cardiovascular or cerebrovascular).

Several large-scale epidemiologic studies indicating that wider retinal venous caliber is strongly associated with the fasting glucose level as well as with diabetes. Another retinal vascular abnormality that is associated with diabetes is an abnormal retinal vascular response to flicker stimulation. Retinal vessel dilatation in response to stimulation with diffuse flicker light occurs due to a phenomenon called neurovascular coupling. This means that increased activity of neurons is associated with an increased retinal metabolism. This leads to a release of endogenous vasodilator substances and increased blood flow. However, previous studies were limited by the fact that retinal vessel diameters and blood flow were not measured simultaneously.

The present study aims to investigate whether the response of retinal vessel diameters and blood flow velocities to flicker stimulation is altered in patients with diabetes. Both parameters will be measured in real time using Fourier Domain Doppler OCT.

研究概览

地位

终止

研究类型

观察性的

注册 (实际的)

1

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Vienna、奥地利、1090
        • Department of Clinical Pharmacology

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

全部

取样方法

非概率样本

研究人群

24 patients with early insulin dependent diabetes and no or mild non-proliferative retinopathy, non-smokers 24 age and sex matched healthy controls, non-smokers

描述

Inclusion Criteria:

  • Men and women aged over 18 years, nonsmokers
  • Normal findings in the medical history (except diabetes) and physical examination unless the investigator considers an abnormality to be clinically irrelevant
  • normal laboratory findings (except diabetes associated parameters) unless the investigator considers the abnormality to be clinically irrelevant
  • normal ophthalmic findings (except mild diabetic retinopathy), Ametropia less than 6 diopters
  • inclusion criterion of patients is type I diabetes with non or mild non-proliferative retinopathy

Exclusion criteria

Any of the following will exclude a healthy subject from the study:

  • Regular use of vasoactive drugs
  • Abuse of alcoholic beverages, participation in a clinical trial in the 3 weeks preceding the study
  • Symptoms of a clinically relevant illness in the 3 weeks before the first study day
  • Blood donation during the previous 3 weeks
  • History or presence of any ocular pathology
  • History or family history of epilepsy
  • Systemic hypertension defined as systolic blood pressure >150mmHg, diastolic blood pressure >90mmHg
  • Pregnancy

Any of the following will exclude a subject with diabetes from the study:

  • Presence of non-insulin dependent diabetes, maturity onset diabetes of the young (MODY diabetes)
  • History or presence of any other diabetes induced vascular pathologies or any other ocular condition other then diabetic retinopathy
  • Best corrected visual acuity <0.8
  • Previous laser photocoagulation treatment
  • Systemic hypertension defined as systolic blood pressure >150mmHg, diastolic blood pressure >90mmHg
  • History or family history of epilepsy
  • Abuse of alcoholic beverages, participation in a clinical trial in the 3 weeks preceding the study
  • Symptoms of a clinically relevant illness in the 3 weeks before the first study day
  • Blood donation during the previous 3 weeks
  • Pregnancy

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
Diabetic retinopathy
Patients with early insulin dependent diabetes and no or mild non-proliferative retinopathy
healthy
healthy control subjects

研究衡量的是什么?

主要结果指标

结果测量
大体时间
Retinal vessel diameters
大体时间:18 months
18 months
Retinal blood flow velocities
大体时间:18 months
18 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2013年3月6日

初级完成 (实际的)

2013年3月6日

研究完成 (实际的)

2013年3月6日

研究注册日期

首次提交

2011年4月11日

首先提交符合 QC 标准的

2011年6月15日

首次发布 (估计)

2011年6月17日

研究记录更新

最后更新发布 (实际的)

2020年2月20日

上次提交的符合 QC 标准的更新

2020年2月19日

最后验证

2020年2月1日

更多信息

与本研究相关的术语

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅